The Human Research Protection Program (HRPP) at AUB is responsible to safeguard the rights and welfare of human subjects participating in Biomedical and Social and Behavioral Sciences (SBS) research activities conducted under the auspices of AUB/AUBMC. It is committed to protect, ensure respect and foster awareness for those rights. This is achieved by governing and authorizing the conduct of research that follows the three ethical principles of the Belmont Report namely: Respect for Persons; Beneficence and Justice; and that abides by the principles of responsible research conduct scientific integrity.
The IRB, that is the core component of HRPP, is the committee formally designated by HRPP to review and approve the conduct of research involving human subjects who are recruited to participate in research activities conducted at AUB/AUBMC and/or by AUB/AUBMC faculty, students and staff, regardless of the funding source or the location of the research.
Important Notice - November 16, 2020: Human Subject Research Conduct During COVID-19 Lockdown:
To ensure the safety and health of both subjects participating in research and the research staff amidst the increase in COVID-19 cases, the IRB expects researchers and their team members to fully adhere to the extra measures that were put forward by AUBMC administration starting Monday November 16, 2020 and until further notice.
Please also refer to the following guidelines regarding human subject research visits to be adhered to during the lockdown and until further notice.
For studies with potential therapeutic benefit (examples: most interventional studies with drugs, devices, procedures):
- The decision about in-person research visits for existing study participants should be made by the study Principal Investigator on a case-by-case basis, weighing risks of person - to - person contact against the potential benefits of the study intervention and monitoring.
- Researchers must pause on enrolling new research participants that require person - to - person contact unless there is a compelling reason that was communicated to the IRB prior to initiating this enrollment.
For studies with no potential therapeutic benefit (examples: social and behavioral sciences research, observational studies, epidemiological studies and studies collecting non-time sensitive biospecimens):
- Person - to - person contact should be halted.
- Research procedures may be modified to reduce person - to - person contact interactions; such modifications should be first communicated to the IRB for review and approval.
Important Notice: New Form to Complete with Every IRB submission:
The IRB is happy to present a guidance document that will help research teams learn about documents that are required to be submitted along with every type of IRB submission and to secure a complete submission and thus expedite the IRB review and hence the approval. This checklist is required with every IRB application. please find the checklist and guidance document on the following link:
Important Notice - March 16, 2020 (Online Submissions):
In view of the evolving situation in Lebanon in regards to COVID-19 pandemic, the HRPP and IRB at AUB will be switching its operations to electronic communications.
Until further notice, please submit your IRB applications, research materials, continuing review forms, study closure forms, and serious adverse events reports (SAEs) as email attachments to firstname.lastname@example.org. In order to help IRB staff efficiently sort and route emails and thus avoid delays, please follow the attached instructions:
IRB submission Updates
HRPP Policies and Procedures Update:
Policy of Patient Enrollment in Clinical Research is updated and posted in the Policies and Procedures section of this website. Please check the policy details and practice instructions. (Patient Enrollment in Clinical Research
Announcement For 2019-2020 Graduate students Planning To Conduct Research Projects That Involve Human Subjects:
The IRB has established a new student
support service to help graduate students with IRB submissions to expedite the review and approval process. (please check the link for details
Important Announcement for IRB Submissions:
In order to expedite and facilitate the review process of your research submissions at the IRB office, please make sure to send the IRB application, research protocol/proposal and all related documents as a hard copy to the IRB office and as a SOFT COPY to the email@example.com
email address. Please specify the name of the PI and the title of the research study in the email subject line to facilitate channeling your application to the right IRB office.